Effective January 1, 2018, OptumRx will be enabling an enhanced prescriber DEA license scope of practice check at point of sale for all Schedule II-V controlled medication claims to prevent payment of scheduled medication claims from unauthorized prescribers.

This scope of practice check will validate submission of a valid, non-expired DEA prescriber license and then match the submitted prescriber’s full two alphabetic letters and 7 digit numeric license number string to the submitted controlled drug GPI. Successful validation of these two steps will allow the claim to proceed to adjudication. *Please see attachments for more information.

*Please see attached for more information.